GEHC gehealthcare.com: Multiplikator Forward P/S

Logo grafis GE Healthcare Corp (GEHC)

GE HealthCare is expanding its influence through targeted acquisitions of AI developers to modernize its software. The forward P/S change on GURU.Markets captures the current valuation dynamics, where 1.50 serves as the current parameter value. Growth potential is based on the integration of neural networks into diagnostics and stable service for a massive installed base of equipment worldwide.

gehealthcare.com - Rasio kapitalisasi marang dodolan sing dikarepake GEHC (periode 28.04.2023 - 13.11.2026)

Rincian metrik lan analitis perusahaan GE HealthCare Inc. (GEHC)

- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:GE HealthCare Technologies (GEHC)
Sampel barang GE HealthCare

Investors struggle to distinguish market noise from an asset's intrinsic value when assessing long-term prospects. The forward P/S ratio compares current market capitalization with projected revenue for the following year, making it possible to identify whether a business is overbought or undervalued. For GE HealthCare (GEHC), the dynamics of this metric are critical, as they reflect the valuation's sensitivity to cost inflation and the risks of reduced government procurement of medical technology.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Mettler-Toledo International Inc. - Multiplikator Forward P/S|WAT (Waters Technologies) - Kapitalisasi marang prakiraan pendapatan|TECH: Multiplikator Forward P/S|BRKR - Rasio kapitalisasi marang dodolan sing dikarepake|AZTA (Azenta) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Varex Imaging Corp (VREX)|Multiplikator Forward P/S SMLR|Multiplikator Forward P/S Butterfly Corp (BFLY)|Rasio rega marang prakiraan pendapatan Mesa Laboratories, Inc. MLAB|quantum-si.com - Rasio rega marang prakiraan pendapatan|NNOX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTRX (Quanterix Corp.)|MASS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CapsoVision (CV)|Rasio rega marang prakiraan pendapatan MaxCyte, Inc.|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)